CG0009
CG0009 is a potent, selective GSK3 inhibitor that suppresses proliferation and triggers apoptosis in breast cancer cells via cyclin D1 depletion and p53-Bax pathway activation. This mechanism supports its investigation as a potential therapeutic strategy, particularly in hormone therapy-resistant breast cancer models, in both in vitro and in vivo research settings.
Product Specifications
CAS Number
944744-57-4
Smiles
C (NC=1C (C) =CC=NC1) (=O) C2=C3C (N=C (N3) C4=CC=C (N (CCN (CC) CC) C) C=C4) =NC=C2
Molecular Formula
C26H31N7O
Molecular Weight
457.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P4071-78A2-APC 200 µL
PIP5K2A, CT (Phosphatidylinositol-5-phosphate 4-kinase Type-2 alpha, 1-phosphatidylinositol-5-phosphate 4-kinase 2-alpha, Diphosphoinositide Kinase 2-alpha, PIP5KIII, Phosphatidylinositol-5-phosphate 4-kinase Type II alpha, PI (5) P 4-kinase Type II alpha, PIP4KII-alpha, PtdIns (4) P-5-kinase B Isoform, PtdIns (4) P-5-kinase C Isoform, PtdIns (5) P-4-kinase Isoform 2-alpha, PIP4K2A, PIP5K2) (APC) discontinued
Sign In for Pricing
View Details 
FAB2769G-100UG 100 µg
Human IL-31 RA Alexa Fluor 488 Antibody (Clone 313308)
Sign In for Pricing
View Details 